Retension Pharmaceuticals and TRex Bio file for US IPOs
Retension Pharmaceuticals and TRex Bio filed paperwork for U.S. initial public offerings, as biotech IPO activity continues heading into the fall window.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.